Clinical trial
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
NCT00002223 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00002223 |
|---|---|
| Title | A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients |
| Official title | Ritonavir (ABT-538)/Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir sulfate, Ritonavir |
| First posted | Aug 31, 2001 |
| Last update posted | Feb 20, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: